Sign In
Buy AVTX
$18.25
-1.14 (-5.88%)
At Close: Jul 31, 2026
3 Hot Penny Stocks To Watch Before Next Week
06:30pm, Thursday, 21'st Sep 2023
Are you looking for the best penny stocks to buy after the stock market dropped today? Believe it or not there are plenty of cheap stocks to watch that are heading higher amid this big drop in major i
3 Penny Stocks To Buy For Under $1, Are They Worth The Risk?
01:54pm, Tuesday, 19'th Sep 2023
Penny stocks priced at less than one dollar seem very appealing. Just a small investment could potentially lead to huge returns.
Avalo (AVTX) Up 45% on Deal to Divest Certain Pipeline Drugs
12:47pm, Wednesday, 13'th Sep 2023
Avalo (AVTX) will receive an upfront payment of $150,000 on selling three compounds to AUG Therapeutics. The company is also eligible to receive milestone payments of up to $45 million.
Avalo to Present at the H.C. Wainwright 25th Annual Global Investment Conference
07:00am, Wednesday, 06'th Sep 2023
WAYNE, Pa. and ROCKVILLE, Md., Sept. 06, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, w
Why Is Avalo Therapeutics (AVTX) Stock Up 19% Today?
08:29am, Friday, 18'th Aug 2023
Avalo Therapeutics (NASDAQ: AVTX ) stock is rising higher on Friday despite a lack of news from the biotechnology company. There haven't been any new press releases or filings from Avalo Therapeutics
Avalo (AVTX) Fails to Meet Goal in Asthma Study, Stock Down 89%
11:18am, Tuesday, 27'th Jun 2023
Avalo (AVTX) announces that it failed to meet the primary endpoint in its mid-stage poorly controlled non-eosinophilic asthma study. The stock falls 89% on Monday following the news.
Avalo to Present at the Jefferies Healthcare Conference
07:00am, Thursday, 01'st Jun 2023
WAYNE, Pa. and ROCKVILLE, Md., June 01, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, wi
Avalo to Present at ATS 2023 Respiratory Innovation Summit
07:00am, Monday, 15'th May 2023
WAYNE, Pa. and ROCKVILLE, Md., May 15, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, wil
Avalo to Present at the 2023 RBC Capital Markets Global Healthcare Conference
07:00am, Wednesday, 10'th May 2023
WAYNE, Pa. and ROCKVILLE, Md., May 10, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., Chief Executive Officer and Chairman of the Board, wil
Avalo Therapeutics, Inc. (AVTX) Reports Q1 Loss, Lags Revenue Estimates
07:44pm, Thursday, 04'th May 2023
Avalo Therapeutics, Inc. (AVTX) came out with a quarterly loss of $0.85 per share versus the Zacks Consensus Estimate of a loss of $0.97. This compares to loss of $2.40 per share a year ago.
The 7 Best Biotech Stocks for Personalized Medicine Investors
06:35am, Tuesday, 25'th Apr 2023
Personalized medicine stocks are hot right now. This form of medicine based on the particular genes, proteins, and other substances in a person's body.
ACER's Stock Down on Failure of Phase II Study, Cash Updates
01:46pm, Monday, 20'th Mar 2023
ACER announces the failure of its phase IIa study of ACER-801 to treat vasomotor symptoms associated with menopause, along with its extinguishing cash runway. Stock down.
Avalo to Present at Oppenheimer's 33rd Annual Healthcare Conference
07:00am, Tuesday, 07'th Mar 2023
WAYNE, Pa. and ROCKVILLE, Md., March 07, 2023 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., President and Chief Executive Officer, will present
Avalo to Present at the H.C. Wainwright Global Investment Conference
07:00am, Thursday, 01'st Sep 2022
WAYNE, Pa. and ROCKVILLE, Md., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., President and Chief Executive Officer, will present
Avalo to Present at the 2022 Jefferies Healthcare Conference
07:30am, Thursday, 02'nd Jun 2022
WAYNE, Pa. and ROCKVILLE, Md., June 02, 2022 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX) announced today that Garry A. Neil, M.D., President and Chief Executive Officer, will present a
